Lycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reveals Immunology Pipeline
LCA-0321 is a LYTAC degrader designed to specifically bind and rapidly deplete anti-TSHR autoantibodies, the underlying cause of Graves’ disease and its extrathyroidal manifestations, including ...
PublicSource on MSN8h
ER visit data for asthma show dip, but advocacy groups still fight for resources and answers
Though asthma-related ER visits have dropped, advocates still worry about industry's impact on health. Could new Allegheny County leadership spell change?
HealthDay on MSN23m
For Less Severe Child Peanut Allergies, Small Doses of Peanut Butter May Help
More than 800,000 U.S. children have what's called "high threshold" peanut allergy, meaning they can tolerate about half a ...
IFLScience4h
Plants Have Given Us Crucial Lifesaving Drugs – And Now We Risk Losing Them
These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...
Royalty Pharma Reports Q4 and Full Year 2024 Results
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...